Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:35 AM UTC
| NCT Number | NCT06121843 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 147 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
| Last Updated on CT.gov | February 18, 2026 (Feb 18, 2026) |
As of July 13, 2026: Clinical trial NCT06121843 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 17 locations across the United States. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06121843 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06121843 was last updated Feb 18, 2026 (February 18, 2026). HelloStudys verifies this status automatically.